KIKK Capital

Chromodynamics is a deep tech company creating a range of multispectral cameras that can take photos of the composition of materials in real time.

Secret View is a community platform that enables users to publish assignments and enhance their feedback-giving skills through e-learning, personal support, and quality checks. Additionally, it operates as a market research agency focused on optimizing customer experiences for businesses. By providing an accessible and cost-effective solution, Secret View allows organizations to gather and learn from real customer feedback, particularly through mystery shopping research. This approach helps retail and hospitality chains effectively measure and improve their customer experience.

River BioMedics is a biotechnology company focused on developing 3D human heart tissue models for pre-clinical drug testing. Recognizing that pharmaceutical companies face significant costs and high failure rates in drug development, particularly due to drug-induced cardiac toxicity, the company aims to enhance drug discovery processes. By creating realistic 3D cardiac tissues that mimic the functioning human heart, River BioMedics provides advanced tools for toxicity screening and target validation. These innovative models offer healthcare professionals valuable insights into the effects of various compounds on cardiac function, thereby facilitating the development of novel cardiac drugs and improving the overall efficiency of drug discovery.

Pepscope is a Dutch biotechnology company that specializes in endogenous protein kinase activity profiling technologies. The company provides microarray and mass spectrometry-based proteomics services, focusing on the development of protein-kinase profiling assays and diagnostics. By offering advanced proteomics services, Pepscope enables the pharmaceutical industry and academic research groups to achieve reproducible results and reliable longitudinal studies. Its innovative approach facilitates robust conclusions in various research applications, enhancing the understanding of protein activity and its implications in biological systems.

Toxys is a Dutch biotech company specializing in in vitro toxicity screening solutions that help identify hazardous and potentially carcinogenic properties of novel compounds during the early stages of product and drug development. The company's technology focuses on detecting genotoxic compounds and assessing developmental toxicity, providing a comprehensive toxicity profile for various substances. This information is critical for clients to make informed decisions about which compounds to advance in their development pipelines. By delivering these insights, Toxys contributes to the creation of safer medicines and products while also aiming to minimize the reliance on animal testing.